In the context of developing new drugs and also on re-profiling old compounds, the CMC is one of the key issues. The session How to Plan Strategically Your CMC For the FDA organized by Support Business Center in collaboration with DDR will be interactive and focused on summarizing those points that are the most relevant and those that usually EU biotech companies miss when planning approaching the FDA for CMC issues.

7:00 pm     Introduction - Xavier Luria, CEO of DDR
7:05 pm     How to Plan Strategically Your CMC For the FDA - David Savello, founding partner of NDA Partners LLC, venture advisor and consultant of the California Institute of Regenerative Medicine
7:30 pm     Discussion
8:00 pm    Networking

Thursday, 2nd July 2015
Time: 7 pm
Place: Support Business Center · C/ Consell de Cent, 375, 2-1 · Barcelona

Limited places. Registration (15 € before 22th June): admin@supportbusinesscenter.com